Immunome (IMNM) Cash from Operations (2019 - 2026)
Immunome (IMNM) posted Cash from Operations of 58638000.0 for Q1 2026, down 22.28% on a QoQ basis from 47953000.0 in Q4 2025, and down 10.52% year-over-year from 65534190.47 in Q1 2025.
Immunome (IMNM) Cash from Operations (2019 - 2026) Analysis & Trends
Immunome's Cash from Operations history runs 8 years deep, the most recent figure standing at 58638000.0 for Q1 2026.
- Quarterly Cash from Operations fell 10.52% year-over-year to 58638000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 196502000.0 (down 28.7% YoY) and the FY2025 annual result came in at 190919000.0, down 72.32% from the prior year.
- Cash from Operations was 58638000.0 for Q1 2026 at Immunome, down from 47953000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 24173000.0 in Q1 2023 and bottomed at 58638000.0 in Q1 2026.
- A 5-year average of 23329941.18 and a median of 17459000.0 in 2023 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2023 — Cash from Operations surged 479.12% — and 2025, when it plunged 374.98%.
- Immunome's Cash from Operations stood at 6683000.0 in 2022, then slumped by 161.24% to 17459000.0 in 2023, then slumped by 140.91% to 42060000.0 in 2024, then fell by 14.01% to 47953000.0 in 2025, then dropped by 22.28% to 58638000.0 in 2026.
- Business Quant data shows IMNM's Cash from Operations at 58638000.0 in Q1 2026, 47953000.0 in Q4 2025, and 40510000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | -58.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58.64 Mn |
| Mar 31, 2026 | -58.64 Mn |
| Dec 31, 2025 | -47.95 Mn |
| Dec 31, 2025 | -47.95 Mn |
| Sep 30, 2025 | -40.51 Mn |
| Sep 30, 2025 | -40.51 Mn |
| Jun 30, 2025 | -49.40 Mn |
| Jun 30, 2025 | -49.40 Mn |
| Mar 31, 2025 | -53.06 Mn |
| Mar 31, 2025 | -53.06 Mn |
| Dec 31, 2024 | -42.06 Mn |
| Dec 31, 2024 | -42.06 Mn |
| Sep 30, 2024 | -34.17 Mn |
| Sep 30, 2024 | -34.17 Mn |
| Jun 30, 2024 | -23.40 Mn |
| Jun 30, 2024 | -23.40 Mn |
| Mar 31, 2024 | -11.17 Mn |
| Mar 31, 2024 | -11.17 Mn |
| Dec 31, 2023 | -17.46 Mn |
| Dec 31, 2023 | -17.46 Mn |